Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Rittenhouse

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1994
The evolution of antimicrobial susceptibility testing methodsJ A Poupard, S F Rittenhouse, L R Walsh
Diagnostic Microbiology and Infectious Disease|September 1, 1996
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agentsS F Rittenhouse, L A Miller, L J Utrup, et al.
Journal of Clinical Microbiology|May 1, 1994
Comparison of three methods for determination of a single MIC of an antimicrobial agentL A Miller, S F Rittenhouse, L J Utrup, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methodsG A Pankuch, M R Jacobs, S F Rittenhouse, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1994
Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolatesL J Utrup, J E Finlay, S F Rittenhouse, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1995
A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolatesS F Rittenhouse, L A Miller, R L Kaplan, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agentsM A Seefeld, W H Miller, K A Newlander, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)D A Heerding, G Chan, W E DeWolf, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|January 1, 1994
The evolution of antimicrobial susceptibility testing methodsJ A Poupard, S F Rittenhouse, L R Walsh
Diagnostic Microbiology and Infectious Disease|September 1, 1996
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agentsS F Rittenhouse, L A Miller, L J Utrup, et al.
Journal of Clinical Microbiology|May 1, 1994
Comparison of three methods for determination of a single MIC of an antimicrobial agentL A Miller, S F Rittenhouse, L J Utrup, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methodsG A Pankuch, M R Jacobs, S F Rittenhouse, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1994
Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolatesL J Utrup, J E Finlay, S F Rittenhouse, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1995
A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolatesS F Rittenhouse, L A Miller, R L Kaplan, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agentsM A Seefeld, W H Miller, K A Newlander, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)D A Heerding, G Chan, W E DeWolf, et al.
Pageof 1